A Phase 1, Double-blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Adult and Elderly Subjects
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2016
At a glance
- Drugs TD 0714 (Primary)
- Indications Cardiovascular disorders; Kidney disorders
- Focus Adverse reactions
- Sponsors Theravance Biopharma
- 17 Nov 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016.
- 08 Nov 2016 Status changed from active, no longer recruiting to completed, as per Theravance Biopharma media release.
- 25 Oct 2016 According to Theravance Biopharma media release, the company has announced positive results, including biomarker data from this trial.